2 results
Not approvedWill not start
To evaluate health related QoL under an oral cyclic treatment with physiological steroid hormones: Duogestan®.
Approved WMOCompleted
To assess, in patients with non-specific low back pain, lasting for over 3 months, the effect of two doses of olpadronate administered intravenously on low back pain as compared to placebo treatment. Assessment of safety and tolerability are also…